KELSEY HARNER: Open Payments
NPI 1306498241 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,985 in 137 payments from 16 companies in 2025. Trend: 2023 $2,801 · 2024 $2,974 · 2025 $2,985
Food & beverage: $2,885Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $552 |
| Galderma Laboratories, L.P. | 15 | $469 |
| UCB, Inc. | 21 | $429 |
| GENZYME CORPORATION | 11 | $411 |
| ABBVIE INC. | 27 | $393 |
| Novartis Pharmaceuticals Corporation | 18 | $182 |
| Regeneron Healthcare Solutions, Inc. | 3 | $92 |
| LEO Pharma Inc. | 3 | $88 |
| Incyte Corporation | 3 | $86 |
| Smith+Nephew, Inc. | 2 | $62 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, Bimzelx, RINVOQ, SKYRIZI, OPZELURA, COLLAGENASE SANTYL.
Industry payments across IN — which companies pay providers there.
